文献速递脑血管病外科神经重症

急性期破裂脑动脉瘤弹簧圈栓塞术前多联抗血小板药物改善临床结局并减少血栓栓塞并发症且不增加出血并发症

Use of Preprocedural, Multiple Antiplatelet Medications for Coil Embolization of Ruptured Cerebral Aneurysm in the Acute Stage Improved Clinical Outcome and Reduced Thromboembolic Complications without Hemorrhagic Complications.
PubMed 文献 · World Neurosurg · 2019-10-08

该多中心研究分析急性蛛网膜下腔出血患者弹簧圈栓塞术前使用抗血小板药物能否减少血栓栓塞并发症。血栓栓塞并发症随抗血小板药物数量增加呈负相关减少,未发生因抗血小板药物导致的出血并发症,多药组术后症状性血管痉挛倾向减少且结局倾向改善,逻辑回归分析显示减少血栓栓塞并发症显著改善临床结局。

要点

  • 急性期破裂脑动脉瘤栓塞术前多联抗血小板可减少血栓栓塞事件。
  • 多联抗血小板未增加出血并发症。
  • 减少血栓栓塞并发症显著改善临床结局。

核心结论

  • 术前多联抗血小板药物减少急性期蛛网膜下腔出血弹簧圈栓塞中的血栓栓塞事件并改善临床结局。

研究设计与样本

  • 按官方方案选择抗血小板药物:阿司匹林200 mg、氯吡格雷150或300 mg、西洛他唑200 mg联合。
  • 所有病例在鞘插入后行全身肝素化。

主要发现

  • 血栓栓塞并发症随抗血小板药物数量增加呈负相关减少。
  • 未发生因抗血小板药物导致的出血并发症。
  • 多药组术后症状性血管痉挛倾向减少,结局也倾向改善。
  • 逻辑回归分析显示减少血栓栓塞并发症显著改善临床结局。

临床怎么用

  • 急性期破裂脑动脉瘤行弹簧圈栓塞前可考虑多联抗血小板药物以降低血栓栓塞风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The most uncontrollable complication during coil embolization of a ruptured cerebral aneurysm is thromboembolic ischemia. We analyzed whether thromboembolic complications could be reduced by using preoperative antiplatelet medications for acute subarachnoid hemorrhage in multicenter fashion. METHODS: We selected antiplatelet medicines according to an official protocol: a combination of 200 mg aspirin, 150 or 300 mg clopidogrel, and 200 mg cilostazol. Systemic heparinization was done after sheath insertion in all cases. One hundred and ten consecutive, ruptured cerebral saccular aneurysms that underwent coiling at our institute were analyzed. Procedure-related thrombus formation on digital subtraction angiography and clinical evidence of ischemia and procedure-related stroke on computed tomography scan were reviewed. RESULTS: Eighty cases (73%) were medicated with multiple antiplatelet medications, 22 cases (20%) were treated with a single medication, and 8 cases (7%) were treated without antiplatelet medication. Thromboembolic complications were reduced in an inverse relationship with the number of antiplatelet medications. Hemorrhagic complications because of antiplatelet medications did not occur. Postoperative symptomatic vasospasm tended to decrease, and outcome also tended to improve in the multiple medications groups. Reduction of thromboembolic complications significantly improved clinical outcome in logistic regression analysis. CONCLUSIONS: Preoperative multiple antiplatelet medication reduced thromboembolic events in coiling during acute stage subarachnoid hemorrhage and improved clinical outcomes.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Shimamura N, Naraoka M, Matsuda N, et al. Use of Preprocedural, Multiple Antiplatelet Medications for Coil Embolization of Ruptured Cerebral Aneurysm in the Acute Stage Improved Clinical Outcome and Reduced Thromboembolic Complications without Hemorrhagic Complications. World Neurosurg. 2019. PMID: 31604135. doi:10.1016/j.wneu.2019.09.149

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。